Vistin Pharma ASA: Third quarter and YTD 2024 financial results
31 Octubre 2024 - 12:40AM
UK Regulatory
Vistin Pharma ASA: Third quarter and YTD 2024 financial results
Oslo, Norway, 31st of October 2024
Vistin Pharma ASA (VISTN) today announces the financial results
for the third quarter of 2024.
Revenue in the third quarter ended at MNOK 106 compared to MNOK
120 in Q3 2023. Sales volume in the quarter decreased compared to
same quarter last year driven by lower sales volume, safety stock
build and lower global Metformin prices. Revenue for first nine
months of 2024 ended at MNOK 316 compared to MNOK 328 YTD last
year.
Third quarter EBITDA ended at record high MNOK 29 compared to
MNOK 27 in Q3 2023. EBITDA positively affected by product mix,
favorable material cost prices and good cost control in quarter.
EBITDA YTD of 2024 equals MNOK 77 compared to MNOK 61 YTD 2023, an
increase of 26%.
The net profit ended at MNOK 16.6 for the third quarter of
2024.
All-time high production volume of 1500MT in the quarter, is
reflecting good operational utilization of both production
lines.
Cash dividend of NOK 0.50 per share distributed in June 2024.
Additional dividend of NOK 0.50 per share to be distributed in
Q4.
The third quarter conference call, which will be held today 31st
of October at 8.30am (CET), will be available via webcast and audio
through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/vbrzzjjk
Telephone conference (online registration):
https://register.vevent.com/register/BI809b345192f14b6882c8bda7de2220b6
The conference call will be held in
English.
Please find the Q3 report and presentation enclosed. The report
will also be made available on www.vistin.com.
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
This information is subject to the disclosure requirements
pursuant to section 5-12 of the Norwegian Securities Trading
Act.
- Vistin Pharma ASA Q3 report 2024
- VistinPharma_Q3_24_presentation
Vistin Pharma Asa (LSE:0RAM)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Vistin Pharma Asa (LSE:0RAM)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
